share_log

Acer Therapeutics Q4 EPS $(0.54) Misses $(0.37) Estimate

Acer Therapeutics Q4 EPS $(0.54) Misses $(0.37) Estimate

Acer Therapeutics 第四季度每股收益 (0.54) 未达到预期 (0.37) 美元
Benzinga ·  2023/03/27 16:03

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 74.19 percent decrease over losses of $(0.31) per share from the same period last year.

宏碁治疗公司(纳斯达克:宏碁)公布季度亏损为每股0.54美元,低于分析师一致预期的0.37美元,跌幅为45.95%。这比去年同期每股亏损0.31美元减少了74.19%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发